A non-interventional observational study assessing the safety and tolerability of ACARIZAX® in adults (18-65 years of age) (RELIEF)

19/10/2021
23/04/2024
EU PAS number:
EUPAS43753
Study
Planned
Documents
Study protocol
No information provided.
Study results
No information provided.
Study report
No information provided.
ENCePP Seal
No information provided.